Gentian Diagnostics ASA (GENT.OL)
NOK 39.0
(0.0%)
NOK 39.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.45 Million | -13.95 Million | -27.05 Million | -7.66 Million | -21.48 Million | -10.89 Million |
| Net Income | -10.35 Million | -23.61 Million | -24.79 Million | -17.46 Million | -39.85 Million | -19.79 Million |
| Depreciation & Amortization | 9.56 Million | 10.24 Million | 7.35 Million | 6.63 Million | 6.13 Million | 3.89 Million |
| Deferred income taxes | -21.51 Million | -32.8 Million | -25.55 Million | - | - | - |
| Stock-based compensation | 3.03 Million | 3.35 Million | 4.63 Million | 3.27 Million | 1.86 Million | - |
| Change in working capital | 7.62 Million | -3.93 Million | -14.24 Million | -101 Thousand | -3.71 Million | -35.71 Thousand |
| Other non-cash items | 27.09 Million | 32.8 Million | 25.55 Million | 1000.00 | 14.08 Million | 5.04 Million |
| Investing Cash Flow | -4.87 Million | -14.66 Million | -12.81 Million | -4.57 Million | -4.03 Million | -6.15 Million |
| Investments in PPE | -4.48 Million | -14.66 Million | -12.81 Million | -6.46 Million | -4.03 Million | -6.15 Million |
| Acquisitions | -390 Thousand | - | - | 1.89 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.53 Million | - | - | 1.89 Million | - | - |
| Financing Cash Flow | -4.59 Million | -4.32 Million | -3.12 Million | -1.51 Million | -1.57 Million | 68.75 Million |
| Debt repayment | -4.59 Million | -4.32 Million | -3.69 Million | -2.46 Million | -1.83 Million | -147.39 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 570 Thousand | 462 Thousand | 259 Thousand | 68.51 Million |
| Other Financing Activities | -4.59 Million | - | - | 497 Thousand | 1000.00 | 379.24 Thousand |
| Accounts receivables | -1.15 Million | -3.55 Million | 1.12 Million | 860 Thousand | 792 Thousand | -2.47 Million |
| Accounts payables | -878 Thousand | -532 Thousand | -833 Thousand | 1.2 Million | 1.31 Million | -253.31 Thousand |
| Inventory | 2.69 Million | -8.76 Million | -8.9 Million | -2.65 Million | -5.12 Million | -2 Million |
| Other working capital | 6.97 Million | 8.91 Million | -5.62 Million | 489 Thousand | -690 Thousand | 1.97 Million |
| Cash at beginning of period | 81.59 Million | 114.93 Million | 157.98 Million | 171.56 Million | 198.63 Million | 146.95 Million |
| Cash at end of period | 87.64 Million | 81.59 Million | 114.93 Million | 157.98 Million | 171.56 Million | 198.63 Million |
| Capital Expenditure | -4.48 Million | -14.66 Million | -12.81 Million | -6.46 Million | -4.03 Million | -6.15 Million |
| Effect of forex changes on cash | 61 Thousand | -395 Thousand | -60 Thousand | 163 Thousand | 31 Thousand | -18.3 Thousand |
| Net cash flow / Change in cash | 6.04 Million | -33.33 Million | -43.04 Million | -13.58 Million | -27.06 Million | 51.68 Million |
| Free Cash Flow | 10.96 Million | -28.61 Million | -39.86 Million | -14.12 Million | -25.52 Million | -17.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.41 Million | 4.73 Million | 4.15 Million | -10.35 Million | -9.79 Million | -816 Thousand |
| Depreciation & Amortization | 2.23 Million | 2.26 Million | 2.2 Million | 9.56 Million | 2.41 Million | 2.37 Million |
| Deferred income taxes | - | - | - | -21.51 Million | 2.52 Million | -1000.00 |
| Stock-based compensation | - | 1.24 Million | 796 Thousand | 3.03 Million | 755 Thousand | 769 Thousand |
| Change in working capital | 10.78 Million | -8.47 Million | -4.59 Million | 7.62 Million | 13.83 Million | -3.47 Million |
| Other non-cash items | 1000.00 | 9.53 Million | 7.49 Million | 27.09 Million | 3.94 Million | -892 Thousand |
| Investing Cash Flow | -2.67 Million | -1.79 Million | -3.18 Million | -4.87 Million | -1.54 Million | -1.15 Million |
| Investments in PPE | -40 Thousand | -1.79 Million | -3.18 Million | -4.48 Million | -1.54 Million | -768 Thousand |
| Acquisitions | - | - | - | -390 Thousand | - | -390 Thousand |
| Investment purchases | - | - | - | - | - | -390 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 390 Thousand |
| Other Investing Activities | 1000.00 | -1000.00 | 1000.00 | - | -1000.00 | 1000.00 |
| Financing Cash Flow | -1.21 Million | -1.31 Million | -1.22 Million | -4.59 Million | -1.15 Million | -1.11 Million |
| Debt repayment | - | -1.31 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.21 Million | -1.31 Million | - | - | - | - |
| Accounts receivables | 13.87 Million | 383 Thousand | -4.25 Million | -1.15 Million | 4.94 Million | -5.12 Million |
| Accounts payables | 357 Thousand | -808 Thousand | 702 Thousand | -878 Thousand | -862 Thousand | -3.69 Million |
| Inventory | -1.39 Million | -4.58 Million | 470 Thousand | 2.69 Million | 4.03 Million | 2.49 Million |
| Other working capital | -2.05 Million | -3.46 Million | -723 Thousand | 6.97 Million | 5.71 Million | 2.85 Million |
| Cash at beginning of period | 81.01 Million | 85.62 Million | 87.64 Million | 81.59 Million | 76.39 Million | 80.72 Million |
| Cash at end of period | 93.79 Million | 81.01 Million | 85.62 Million | 87.64 Million | 87.64 Million | 76.39 Million |
| Capital Expenditure | -40 Thousand | -1.79 Million | -3.18 Million | -4.48 Million | -1.54 Million | -768 Thousand |
| Effect of forex changes on cash | - | -16 Thousand | -175 Thousand | 61 Thousand | 256 Thousand | -21 Thousand |
| Net cash flow / Change in cash | 12.78 Million | -4.6 Million | -2.02 Million | 6.04 Million | 11.24 Million | -4.33 Million |
| Free Cash Flow | 16.39 Million | -3.27 Million | -623 Thousand | 10.96 Million | 12.14 Million | -2.8 Million |
EGOXF
2529
5548
4202
BNZ
052690